New insights into the role of peroxisome proliferator-activated receptors in regulating the inflammatory response after tissue injury

PPAR Research

Volumn , Issue , 2012, Pages

  Neher, Miriam D ^a   Weckbach, Sebastian ^a   Huber Lang, Markus S ^b   Stahel, Philip F ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIGLITAZONE; CYTOKINE; FENOFIBRATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; ROSIGLITAZONE;

ANTIINFLAMMATORY ACTIVITY; GENETIC TRANSCRIPTION; INFLAMMATION; LIGAND BINDING; NERVOUS SYSTEM INJURY; PATHOPHYSIOLOGY; REPERFUSION INJURY; REVIEW; SEPSIS; SHOCK; TISSUE INJURY; WOUND HEALING;

EID: 84858315888     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/728461     Document Type: Review

References (135)

1. Kauvar D. S., Wade C. E., The epidemiology and modern management of traumatic hemorrhage: US and international perspectives Critical Care 2005 9 supplement 5 S1 S9
2. Bianchi M. E., Manfredi A. A., Dangers in and out Science 2009 323 5922 1683 1684
3. Stahel P. F., Smith W. R., Moore E. E., Role of biological modifiers regulating the immune response after trauma Injury 2007 38 12 1409 1422 (Pubitemid 350192403)
4. Keel M., Trentz O., Pathophysiology of polytrauma Injury 2005 36 6 691 709 (Pubitemid 40732303)
5. Cuzzocrea S., Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury Vascular Pharmacology 2004 41 6 187 195 (Pubitemid 40094612)
6. Stahel P. F., Smith W. R., Bruchis J., Rabb C. H., Peroxisome proliferator-activated receptors: Key regulators of neuroinflammation after traumatic brain injury PPAR Research 2008 2008
7. Giaginis C., Tsourouflis G., Theocharis S., Peroxisome proliferator-activated receptor- (PPAR- ) ligands: novel pharmacological agents in the treatment of ischemia reperfusion injury Current Molecular Medicine 2008 8 6 562 579
8. Von Knethen A., Soller M., Brne B., Peroxisome proliferator-activated receptor (PPAR ) and sepsis Archivum Immunologiae et Therapiae Experimentalis 2007 55 1 19 25 (Pubitemid 46294894)
9. Willson T. M., Brown P. J., Sternbach D. D., Henke B. R., The PPARs: from orphan receptors to drug discovery Journal of Medicinal Chemistry 2000 43 4 527 550 (Pubitemid 30127149)
10. Staels B., Fruchart J. C., Therapeutic roles of peroxisome proliferator-activated receptor agonists Diabetes 2005 54 8 2460 2470 (Pubitemid 41134276)
11. Daynes R. A., Jones D. C., Emerging roles of PPARs in inflammation and immunity Nature Reviews Immunology 2002 2 10 748 759 (Pubitemid 37328715)
12. Abdelrahman M., Sivarajah A., Thiemermann C., Beneficial effects of PPAR- ligands in ischemia-reperfusion injury, inflammation and shock Cardiovascular Research 2005 65 4 772 781 (Pubitemid 40249723)
13. van Neerven S., Mey J., RAR/RXR and PPAR/RXR signaling in spinal cord injury PPAR Research 2007 2007
14. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocrine Reviews 1999 20 5 649 688 (Pubitemid 30650602)
15. Michalik L., Wahli W., Involvement of PPAR nuclear receptors in tissue injury and wound repair Journal of Clinical Investigation 2006 116 3 598 606 (Pubitemid 43326864)
16. Youssef J., Badr M., Peroxisome proliferator-activated receptors and cancer: challenges and opportunities British Journal of Pharmacology 2011 164 1 68 82
17. Plutzky J., The PPAR-RXR transcriptional complex in the vasculature: energy in the balance Circulation Research 2011 108 8 1002 1016
18. Montagner A., Rando G., Degueurce G., Leuenberger N., Michalik L., Wahli W., New insights into the role of PPARs Prostaglandins Leukotrienes and Essential Fatty Acids 2011 85 5 235 243
19. Yessoufou A., Wahli W., Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels Swiss Medical Weekly 2010 140 4 10
20. McMillan T. M., Teasdale G. M., Death rate is increased for at least 7 years after head injury: a prospective study Brain 2007 130, part 10 2520 2527 (Pubitemid 47511707)
21. Schmidt O. I., Heyde C. E., Ertel W., Stahel P. F., Closed head injuryan inflammatory disease? Brain Research Reviews 2005 48 2 388 399 (Pubitemid 40585769)
22. Gaetz M., The neurophysiology of brain injury Clinical Neurophysiology 2004 115 1 4 18 (Pubitemid 38045590)
23. Bright J. J., Kanakasabai S., Chearwae W., Chakraborty S., PPAR regulation of inflammatory signaling in CNS diseases PPAR Research 2008 2008
24. Kapadia R., Yi J. H., Vemuganti R., Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists Frontiers in Bioscience 2008 13 5 1813 1826 (Pubitemid 351599735)
25. Cullingford T. E., Bhakoo K., Peuchen S., Dolphin C. T., Patel R., Clark J. B., Distribution of mRNAs encoding the peroxisome proliferator-activated receptor,, and and the retinoid X receptor,, and in rat central nervous system Journal of Neurochemistry 1998 70 4 1366 1375 (Pubitemid 28136948)
26. Moreno S., Farioli-vecchioli S., Cer M. P., Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 2004 123 1 131 145 (Pubitemid 37518482)
27. Yi J. H., Park S. W., Brooks N., Lang B. T., Vemuganti R., PPAR agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms Brain Research 2008 1244 164 172
28. Almad A., McTigue D. M., Chronic expression of PPAR- by oligodendrocyte lineage cells in the injured rat spinal cord Journal of Comparative Neurology 2010 518 6 785 799
29. Feng D., Zhang Y., Chen G., Cortical expression of peroxisome proliferator-activated receptor- after human brain contusion Journal of International Medical Research 2008 36 4 783 791
30. Bordet R., Gelé P., Duriez P., Fruchart J. C., PPARs: a new target for neuroprotection Journal of Neurology, Neurosurgery and Psychiatry 2006 77 3 285 286
31. Qi L., Jacob A., Wang P., Wu R., Peroxisome proliferator activated receptor- and traumatic brain injury International Journal of Clinical and Experimental Medicine 2010 3 4 283 292
32. Bordet R., Ouk T., Petrault O., Gelé P., Gautier S., Laprais M., Deplanque D., Duriez P., Staels B., Fruchart J. C., Bastide M., PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases Biochemical Society Transactions 2006 34, part 6 1341 1346 (Pubitemid 46769051)
33. Bernando A., Minghetti L., PPAR- agonists as regulators of microglial activation and brain inflammation Current Pharmaceutical Design 2006 12 1 93 109
34. Hyong A., Jadhav V., Lee S., Tong W., Rowe J., Zhang J. H., Tang J., Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents Brain Research 2008 1215 C 218 224
35. Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A. C., Dianzani C., Danni O., Thiemermann C., Fantozzi R., Modulation of the oxidative stress and inflammatory response by PPAR- agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion European Journal of Pharmacology 2006 530 1-2 70 80 (Pubitemid 43037126)
36. Chen X. R., Besson V. C., Palmier B., Garcia Y., Plotkine M., Marchand-Leroux C., Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury Journal of Neurotrauma 2007 24 7 1119 1131 (Pubitemid 47106286)
37. Zhao X., Zhang Y., Strong R., Grotta J. C., Aronowski J., 15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats Journal of Cerebral Blood Flow and Metabolism 2006 26 6 811 820
38. Genovese T., Mazzon E., Di Paola R., Cannav G., Mui C., Bramanti P., Cuzzocrea S., Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma Experimental Neurology 2005 194 1 267 278 (Pubitemid 40719761)
39. Genovese T., Esposito E., Mazzon E., Crisafulli C., Paterniti I., Di Paola R., Galuppo M., Bramanti P., Cuzzocrea S., PPAR- modulate the anti-inflammatory effect of glucocorticoids in the secondary damage in experimental spinal cord trauma Pharmacological Research 2009 59 5 338 350
40. Esposito E., Cuzzocrea S., Targeting the peroxisome proliferator- activated receptors (PPARs) in spinal cord injury Expert Opinion on Therapeutic Targets 2011 15 8 943 959
41. Besson V. C., Chen X. R., Plotkine M., Marchand-Verrecchia C., Fenofibrate, a peroxisome proliferator-activated receptor agonist, exerts neuroprotective effects in traumatic brain injury Neuroscience Letters 2005 388 1 7 12 (Pubitemid 41569361)
42. Xiao R. C., Besson V. C., Beziaud T., Plotkine M., Marchand-Leroux C., Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, on experimental traumatic brain injury Journal of Pharmacology and Experimental Therapeutics 2008 326 3 966 974
43. McTigue D. M., Potential therapeutic targets for PPAR after spinal cord injury PPAR Research 2008 2008
44. Sauerbeck A., Gao J., Readnower R., Liu M., Pauly J. R., Bing G., Sullivan P. G., Pioglitazone attenuates mitochondrial dysfunction, cognitive impairment, cortical tissue loss, and inflammation following traumatic brain injury Experimental Neurology 2011 227 1 128 135
45. Semple B. D., Noble-Haeusslein L. J., Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome proliferator-activated receptors Experimental Neurology 2011 229 2 195 197
46. Zhang Q., Hu W., Meng B., Tang T., PPAR agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats Neurological Research 2010 32 8 852 859
47. Park S. W., Yi J. H., Miranpuri G., Satriotomo I., Bowen K., Resnick D. K., Vemuganti R., Thiazolidinedione class of peroxisome proliferator-activated receptor agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats Journal of Pharmacology and Experimental Therapeutics 2007 320 3 1002 1012 (Pubitemid 46294061)
48. McTigue D. M., Tripathi R., Wei P., Lash A. T., The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury Experimental Neurology 2007 205 2 396 406 (Pubitemid 46755761)
49. Zhang Q., Huang C., Tang T., Shi Q., Yang H., Comparative neuroprotective effects of methylprednisolone and rosiglitazone, a peroxisome proliferator-activated receptor- following spinal cord injury Neurosciences 2011 16 1 46 52
50. Mechoulam R., Panikashvili D., Shohami E., Cannabinoids and brain injury: therapeutic implications Trends in Molecular Medicine 2002 8 2 58 61 (Pubitemid 34094440)
51. Mechoulam R., Shohami E., Endocannabinoids and traumatic brain injury Molecular Neurobiology 2007 36 1 68 74 (Pubitemid 351360359)
52. Bayir H., Clark R. S. B., Kochanek P. M., Promising strategies to minimize secondary brain injury after head trauma Critical Care Medicine 2003 31 1 S112 S117
53. Sun Y., Bennett A., Cannabinoids: a new group of agonists of PPARs PPAR Research 2007 2007
54. Panikashvili D., Simeonidou C., Ben-Shabat S., Hanu L., Breuer A., Mechoulam R., Shohami E., An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 2001 413 6855 527 531 (Pubitemid 32938751)
55. Gallily R., Breuer A., Mechoulam R., 2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor- production in murine macrophages, and in mice European Journal of Pharmacology 2000 406 1 R5 R7
56. Shohami E., Novikov M., Mechoulam R., A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat Journal of Neurotrauma 1993 10 2 109 119 (Pubitemid 23209478)
57. Shohami E., Gallily R., Mechoulam R., Bass R., Ben-Hur T., Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF- inhibitor and an effective neuroprotectant Journal of Neuroimmunology 1997 72 2 169 177 (Pubitemid 27062773)
58. Rockwell C. E., Snider N. T., Thompson J. T., Vanden Heuvel J. P., Kaminski N. E., Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor independently of cannabinoid receptors 1 and 2 Molecular Pharmacology 2006 70 1 101 111
59. Fu J., Gaetani S., Oveisi F., Lo Verme J., Serrano A., De Fonseca F. R., Rosengarth A., Luecke H., Di Giacomo B., Tarzia G., Piomelli D., Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR- Nature 2003 425 6953 90 93 (Pubitemid 37101723)
60. O'Sullivan S. E., Tarling E. J., Bennett A. J., Kendall D. A., Randall M. D., Novel time-dependent vascular actions of 9- tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma Biochemical and Biophysical Research Communications 2005 337 3 824 831 (Pubitemid 41446988)
61. Knoller N., Levi L., Shoshan I., Reichenthal E., Razon N., Rappaport Z. H., Biegon A., Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial Critical Care Medicine 2002 30 3 548 554 (Pubitemid 34214615)
62. Narayan R. K., Michel M. E., Ansell B., Baethmann A., Biegon A., Bracken M. B., Bullock M. R., Choi S. C., Clifton G. L., Contant C. F., Coplin W. M., Dietrich W. D., Ghajar J., Grady S. M., Grossman R. G., Hall E. D., Heetderks W., Hovda D. A., Jallo J., Katz R. L., Knoller N., Kochanek P. M., Maas A. I., Majde J., Marion D. W., Marmarou A., Marshall L. F., McIntosh T. K., Miller E., Mohberg N., Muizelaar J. P., Pitts L. H., Quinn P., Riesenfeld G., Robertson C. S., Strauss K. I., Teasdale G., Temkin N., Tuma R., Wade C., Walker M. D., Weinrich M., Whyte J., Wilberger J., Young A. B., Yurkewicz L., Clinical trials in head injury Journal of Neurotrauma 2002 19 5 503 557 (Pubitemid 34587299)
63. Heyndrickx G. R., Early reperfusion phenomena Seminars in Cardiothoracic and Vascular Anesthesia 2006 10 3 236 241 (Pubitemid 44221894)
64. Matsuyama M., Yoshimura R., Kawahito Y., Sano H., Chargui J., Touraine J. L., Nakatani T., Relationship between peroxisome proliferator-activated receptor- and renal ischemia-reperfusion injury Molecular Medicine Reports 2008 1 4 499 503
65. Yoshimura R., Matsuyama M., Segawa Y., Tsuchida K., Takemoto Y., Kuratsukuri K., Kawahito Y., Shinka T., Sano H., Nakatani T., Study of peroxisome proliferator-activated receptor (PPAR)- in renal ischemia-reperfusion injury Transplantation Proceedings 2004 36 7 1946 1948 (Pubitemid 39424288)
66. Zhao Y., Patzer A., Herdegen T., Gohlke P., Culman J., Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats FASEB Journal 2006 20 8 1162 1175 (Pubitemid 44943912)
67. Lee C. H., Park O. K., Yoo K. Y., Byun K., Lee B., Choi J. H., Hwang I. K., Kim Y. M., Won M. H., The role of peroxisome proliferator-activated receptor, and effects of its agonist, rosiglitazone, on transient cerebral ischemic damage Journal of the Neurological Sciences 2011 300 1-2 120 129
68. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Patel N. S. A., Di Paola R., Genovese T., Chatterjee P. K., Di Rosa M., Caputi A. P., Thiemermann C., Rosiglitazone and 15-deoxy-12,14-prostaglandin J 2, ligands of the peroxisome proliferator-activated receptor- (PPAR- ), reduce ischaemia/reperfusion injury of the gut British Journal of Pharmacology 2003 140 2 366 376 (Pubitemid 37249197)
69. Chatterjee P. K., Patel N. S. A., Cuzzocrea S., Brown P. A. J., Stewart K. N., Mota-Filipe H., Britti D., Eberhardt W., Pfeilschifter J., Thiemermann C., The cyclopentenone prostaglandin 15-deoxy-12,14- prostaglandin J2 ameliorates ischemic acute renal failure Cardiovascular Research 2004 61 3 630 643 (Pubitemid 38210168)
70. Okada M., Yan S. F., Pinsky D. J., Peroxisome proliferator-activated receptor- (PPAR- ) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets FASEB Journal 2002 16 14 1861 1868 (Pubitemid 35462604)
71. Guo Q., Wang G., Namura S., Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice Journal of Cerebral Blood Flow and Metabolism 2010 30 1 70 78
72. Cuzzocrea S., Di Paola R., Mazzon E., Genovese T., Mui C., Caputi A. P., WY 14643, a potent exogenous PPAR- ligand, reduces intestinal injury associated with splanchnic artery occlusion shock Shock 2004 22 4 340 346 (Pubitemid 39468973)
73. Deplanque D., Gelé P., Pétrault O., Six I., Furman C., Bouly M., Nion S., Dupuis B., Leys D., Fruchart J. C., Cecchelli R., Staels B., Duriez P., Bordet R., Peroxisome proliferator-activated receptor- activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment Journal of Neuroscience 2003 23 15 6264 6271 (Pubitemid 36875628)
74. Ito K., Shimada J., Kato D., Toda S., Takagi T., Naito Y., Yoshikawa T., Kitamura N., Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor- ligand, on lung ischemia-reperfusion injury in rats European Journal of Cardio-thoracic Surgery 2004 25 4 530 536 (Pubitemid 38376065)
75. Honda T., Kaikita K., Tsujita K., Hayasaki T., Matsukawa M., Fuchigami S., Sugiyama S., Sakashita N., Ogawa H., Takeya M., Pioglitazone, a peroxisome proliferator-activated receptor- agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders Journal of Molecular and Cellular Cardiology 2008 44 5 915 926
76. Luo Y., Yin W., Signore A. P., Zhang F., Hong Z., Wang S., Graham S. H., Chen J., Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor- agonist rosiglitazone Journal of Neurochemistry 2006 97 2 435 448
77. Sivarajah A., Chatterjee P. K., Patel N. S. A., Todorovic Z., Hattori Y., Brown P. A. J., Stewart K. N., Mota-Filipe H., Cuzzocrea S., Thiemermann C., Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury American Journal of Nephrology 2003 23 4 267 276 (Pubitemid 36980722)
78. Villegas I., Martn A. R., Toma W., Alarcn de la Lastra C., Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation European Journal of Pharmacology 2004 505 13 195 203 (Pubitemid 39535692)
79. Doi S., Masaki T., Arakawa T., Takahashi S., Kawai T., Nakashima A., Naito T., Kohno N., Yorioka N., Protective effects of peroxisome proliferator-activated receptor ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury Transplantation 2007 84 2 207 213 (Pubitemid 47205754)
80. Di Paola R., Esposito E., Mazzon E., Paterniti I., Galuppo M., Cuzzocrea S., GW0742, a selective PPAR- / agonist, contributes to the resolution of inflammation after gut ischemia/reperfusion injury Journal of Leukocyte Biology 2010 88 2 291 301
81. Li D., Chen K., Sinha N., Zhang X., Wang Y., Sinha A. K., Romeo F., Mehta J. L., The effects of PPAR- ligand pioglitazone on platelet aggregation and arterial thrombus formation Cardiovascular Research 2005 65 4 907 912 (Pubitemid 40253577)
82. Paller M. S., The cell biology of reperfusion injury in the kidney Journal of Investigative Medicine 1994 42 4 632 639
83. Patel N. S. A., di Paola R., Mazzon E., Britti D., Thiemermann C., Cuzzocrea S., Peroxisome proliferator-activated receptor- contributes to the resolution of inflammation after renal ischemia/reperfusion injury Journal of Pharmacology and Experimental Therapeutics 2009 328 2 635 643
84. Collino M., Benetti E., Miglio G., Castiglia S., Rosa A. C., Aragno M., Thiemermann C., Fantozzi R., Peroxisome proliferator-activated receptor / agonism protects the kidney against ischemia/reperfusion injury in diabetic rats Free Radical Biology and Medicine 2011 50 2 345 353
85. Letavernier E., Perez J., Joye E., Bellocq A., Fouqueray B., Haymann J. P., Heudes D., Wahli W., Desvergne B., Baud L., Peroxisome proliferator- activated receptor / exerts a strong protection from ischemic acute renal failure Journal of the American Society of Nephrology 2005 16 8 2395 2402 (Pubitemid 41725057)
86. Chen H. H., Chen T. W., Lin H., Prostacyclin-induced peroxisome proliferator-activated receptor- translocation attenuates NF- B and TNF- activation after renal ischemia-reperfusion injury American Journal of PhysiologyRenal Physiology 2009 297 4 F1109 F1118
87. Portilla D., Dai G., Peters J. M., Gonzalez F. J., Crew M. D., Proia A. D., Etomoxir-induced PPAR -modulated enzymes protect during acute renal failure American Journal of PhysiologyRenal Physiology 2000 278 4 F667 F675
88. Li S., Nagothu K. K., Desai V., Lee T., Branham W., Moland C., Megyesi J. K., Crew M. D., Portilla D., Transgenic expression of proximal tubule peroxisome proliferator-activated receptor- in mice confers protection during acute kidney injury Kidney International 2009 76 10 1049 1062
89. King R. C., Binns O. A. R., Rodriguez F., Kanithanon R. C., Daniel T. M., Spotnitz W. D., Tribble C. G., Kron I. L., Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation Annals of Thoracic Surgery 2000 69 6 1681 1685 (Pubitemid 30445505)
90. Cappell M. S., Intestinal (mesenteric) vasculopathy II. Ischemic colitis and chronic mesenteric ischemia Gastroenterology Clinics of North America 1998 27 4 827 860 (Pubitemid 29023061)
91. Ichikawa H., Naito Y., Takagi T., Tomatsuri N., Yoshida N., Yoshikawa T., A specific peroxisome proliferator-induced receptor- (PPAR- ) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats Redox Report 2002 7 5 343 346 (Pubitemid 36032930)
92. Sato N., Moore F. A., Kone B. C., Zou L., Smith M. A., Childs M. A., Moore-Olufemi S., Schultz S. G., Kozar R. A., Differential induction of PPAR- by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel American Journal of PhysiologyGastrointestinal and Liver Physiology 2006 290 4 G616 G623
93. Ban K., Kozar R. A., Enteral glutamine: a novel mediator of PPAR in the postischemic gut Journal of Leukocyte Biology 2008 84 3 595 599
94. Hankey G. J., Warlow C. P., Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations Lancet 1999 354 9188 1457 1463 (Pubitemid 29494766)
95. Fatehi-Hassanabad Z., Tasker R. A., Peroxisome proliferator-activated receptor- (PPAR- ) activation confers functional neuroprotection in global ischemia Neurotoxicity Research 2011 19 3 462 471
96. Rubins H. B., Davenport J., Babikian V., Brass L. M., Collins D., Wexler L., Wagner S., Papademetriou V., Rutan G., Robins S. J., Reduction in stroke with gemfibrozil in men with coronary heart disease and low HDL cholesterol the veterans affairs HDL intervention trial (VA-HIT) Circulation 2001 103 23 2828 2833 (Pubitemid 32550072)
97. Iwashita A., Muramatsu Y., Yamazaki T., Muramoto M., Kita Y., Yamazaki S., Mihara K., Moriguchi A., Matsuoka N., Neuroprotective efficacy of the peroxisome proliferator-activated receptor -selective agonists in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 2007 320 3 1087 1096 (Pubitemid 46294065)
98. Victor N. A., Wanderi E. W., Gamboa J., Zhao X., Aronowski J., Deininger K., Lust W. D., Landreth G. E., Sundararajan S., Altered PPAR expression and activation after transient focal ischemia in rats European Journal of Neuroscience 2006 24 6 1653 1663 (Pubitemid 44427534)
99. Lin T. N., Cheung W. M., Wu J. S., Chen J. J., Lin H., Chen J. J., Liou J. Y., Shyue S. K., Wu K. K., 15d-prostaglandin J2 protects brain from ischemia-reperfusion injury Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 3 481 487
100. Sundararajan S., Gamboa J. L., Victor N. A., Wanderi E. W., Lust W. D., Landreth G. E., Peroxisome proliferator-activated receptor- ligands reduce inflammation and infarction size in transient focal ischemia Neuroscience 2005 130 3 685 696 (Pubitemid 39601441)
101. Shimazu T., Inoue I., Araki N., Asano Y., Sawada M., Furuya D., Nagoya H., Greenberg J. H., A peroxisome proliferator-activated receptor- agonist reduces infarct size in transient but not in permanent ischemia Stroke 2005 36 2 353 359 (Pubitemid 40170822)
102. Gamboa J., Blankenship D. A., Niemi J. P., Landreth G. E., Karl M., Hilow E., Sundararajan S., Extension of the neuroprotective time window for thiazolidinediones in ischemic stroke is dependent on time of reperfusion Neuroscience 2010 170 3 846 857
103. Kasahara Y., Taguchi A., Uno H., Nakano A., Nakagomi T., Hirose H., Stern D. M., Matsuyama T., Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia Brain Research 2010 1340 C 70 80
104. Kaplan J. M., Cook J. A., Hake P. W., O'Connor M., Burroughs T. J., Zingarelli B., 15-Deoxy-12,14-prostaglandin J2 (15D-PGJ 2), a peroxisome proliferator activated receptor ligand, reduces tissue leukosequestration and mortality in endotoxic shock Shock 2005 24 1 59 65 (Pubitemid 40946596)
105. Zingarelli B., Chima R., O'Connor M., Piraino G., Denenberg A., Hake P. W., Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor- in hemorrhagic shock American Journal of PhysiologyGastrointestinal and Liver Physiology 2010 298 1 G133 G141
106. Kapoor A., Shintani Y., Collino M., Osuchowski M. F., Busch D., Patel N. S. A., Sepodes B., Castiglia S., Fantozzi R., Bishop-Bailey D., Mota-Filipe H., Yaqoob M. M., Suzuki K., Bahrami S., Desvergne B., Mitchell J. A., Thiemermann C., Protective role of peroxisome proliferator-activated receptor- / in septic shock American Journal of Respiratory and Critical Care Medicine 2010 182 12 1506 1515
107. Wiel E., Lebuffe G., Robin E., Gasan G., Corseaux D., Tavernier B., Jude B., Bordet R., Vallet B., Pretreatment with peroxysome proliferator-activated receptor agonist fenofibrate protects endothelium in rabbit Escherichia coli endotoxin-induced shock Intensive Care Medicine 2005 31 9 1269 1279 (Pubitemid 41355806)
108. Soller M., Tautenhahn A., Brne B., Zacharowski K., John S., Link H., Von Knethen A., Peroxisome proliferator-activated receptor contributes to T lymphocyte apoptosis during sepsis Journal of Leukocyte Biology 2006 79 1 235 243 (Pubitemid 43054269)
109. Reddy R. C., Narala V. R., Keshamouni V. G., Milam J. E., Newstead M. W., Standiford T. J., Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor- Blood 2008 112 10 4250 4258
110. Wu W. T., Lee C. C., Lee C. J., Subeq Y. M., Lee R. P., Hsu B. G., Rosiglitazone ameliorates endotoxin-induced organ damage in conscious rats Biological Research for Nursing 2011 13 1 38 43
111. Abdelrahman M., Collin M., Thiemermann C., The peroxisome proliferator-activated receptor- ligand 15-deoxy 12,14 prostaglandin J2 reduces the organ injury in hemorrhagic shock Shock 2004 22 6 555 561 (Pubitemid 39576584)
112. Chima R. S., Hake P. W., Piraino G., Mangeshkar P., Denenberg A., Zingarelli B., Ciglitazone ameliorates lung inflammation by modulating the inhibitor b protein kinase/nuclear factor- B pathway after hemorrhagic shock Critical Care Medicine 2008 36 10 2849 2857
113. Chima R. S., Hake P. W., Piraino G., Mangeshkar P., O'Connor M., Zingarelli B., Ciglitazone, a novel inhibitor of lung apoptosis following hemorrhagic shock International Journal of Clinical and Experimental Medicine 2010 3 1 1 9
114. Zingarelli B., Sheehan M., Hake P. W., O'Connor M., Denenberg A., Cook J. A., Peroxisome proliferator activator receptor- ligands, 15-deoxy-12,14- prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways Journal of Immunology 2003 171 12 6827 6837 (Pubitemid 37532118)
115. Zingarelli B., Piraino G., Hake P. W., O'Connor M., Denenberg A., Fan H., Cook J. A., Peroxisome proliferator-activated receptor regulates inflammation via NF- B signaling in polymicrobial sepsis American Journal of Pathology 2010 177 4 1834 1847
116. Cuzzocrea S., Pisano B., Dugo L., Ianaro A., Patel N. S. A., Di Paola R., Genovese T., Chatterjee P. K., Fulia F., Cuzzocrea E., Di Rosa M., Caputi A. P., Thiemermann C., Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-, reduces the development of nonseptic shock induced by zymosan in mice Critical Care Medicine 2004 32 2 457 466 (Pubitemid 38234126)
117. Galuppo M., Di Paola R., Mazzon E., Genovese T., Crisafulli C., Paterniti I., Cuzzocrea E., Bramanti P., Kapoor A., Thiemermann C., Cuzzocrea S., Role of PPAR- in the development of zymosan-induced multiple organ failure: an experiment mice study Journal of Inflammation 2010 7, article 12
118. Steiner D. F., Cunningham D., Spigelman L., Aten B., Insulin biosynthesis: evidence for a precursor Science 1967 157 3789 697 700
119. Al-Rasheed N. M., Chanai R. S., Baines R. J., Willars G. B., Brunskill N. J., Ligand-independent activation of peroxisome proliferator-activated receptor- by insulin and C-peptide in kidney proximal tubular cells: dependent on phosphatidylinositol 3-kinase activity Journal of Biological Chemistry 2004 279 48 49747 49754 (Pubitemid 39577779)
120. Young L. H., Ikeda Y., Scalia R., Lefer A. M., C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion American Journal of PhysiologyHeart and Circulatory Physiology 2000 279 4 H1453 H1459
121. Vish M. G., Mangeshkar P., Piraino G., Denenberg A., Hake P. W., O'Connor M., Zingarelli B., Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice Critical Care Medicine 2007 35 5 1348 1355 (Pubitemid 46642665)
122. Chima R. S., LaMontagne T., Piraino G., Hake P. W., Denenberg A., Zingarelli B., C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock American Journal of PhysiologyLung Cellular and Molecular Physiology 2011 300 5 L730 L739
123. Wu R., Zhou M., Wang P., Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF- in macrophage cell line and rat Kupffer cells Regulatory Peptides 2003 112 13 19 26 (Pubitemid 36351599)
124. Miksa M., Wu R., Cui X., Dong W., Das P., Simms H. H., Ravikumar T. S., Wang P., Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor- Journal of Immunology 2007 179 9 6263 6272
125. Greene M. E., Blumberg B., McBride O. W., Yi H. F., Kronquist K., Kwan K., Hsieh L., Greene G., Nimer S. D., isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping Gene Expression 1995 4 4-5 281 299
126. Schmidt M. V., Paulus P., Kuhn A. M., Weigert A., Morbitzer V., Zacharowski K., Kempf V. A. J., Brne B., Von Knethen A., Peroxisome proliferator-activated receptor g-induced T cell apoptosis reduces survival during polymicrobial sepsis American Journal of Respiratory and Critical Care Medicine 2011 184 1 64 74
127. Michalik L., Desvergne B., Tan N. S., Basu-Modak S., Escher P., Rieusset J., Peters J. M., Kaya G., Gonzalez F. J., Zakany J., Metzger D., Chambon P., Duboule D., Wahli W., Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) and PPAR mutant mice Journal of Cell Biology 2001 154 4 799 814 (Pubitemid 34292961)
128. Dubrac S., Schmuth M., PPAR-alpha in cutaneous inflammation Dermato-Endocrinology 2011 3 1 23 26
129. Icre G., Wahli W., Michalik L., Functions of the peroxisome proliferator-activated receptor (PPAR) and in skin homeostasis, epithelial repair, and morphogenesis Journal of Investigative Dermatology Symposium Proceedings 2006 11 1 30 35 (Pubitemid 44413142)
130. Tan N. S., Michalik L., Noy N., Yasmin R., Pacot C., Heim M., Flhmann B., Desvergne B., Wahli W., Critical roles of PPAR / in keratinocyte response to inflammation Genes and Development 2001 15 24 3263 3277 (Pubitemid 34008192)
131. Di-Po N., Tan N. S., Michalik L., Wahli W., Desvergne B., Antiapoptotic role of PPAR in keratinocytes via transcriptional control of the Akt1 signaling pathway Molecular Cell 2002 10 4 721 733 (Pubitemid 35335629)
132. Nguan S. T., Icre G., Montagner A., Bordier-Ten Heggeler B., Wahli W., Michalik L., The nuclear hormone receptor peroxisome proliferator-activated receptor / potentiates cell chemotactism, polarization, and migration Molecular and Cellular Biology 2007 27 20 7161 7175 (Pubitemid 47549752)
133. Tan N. S., Michalik L., Di-Po N., Ng C. Y., Mermod N., Roberts A. B., Desvergne B., Wahli W., Essential role of Smad3 in the inhibition of inflammation-induced PPAR / expression EMBO Journal 2004 23 21 4211 4221 (Pubitemid 39546159)
134. Tan N. S., Michalik L., Desvergne B., Wahli W., Genetic- or transforming growth factor- 1-induced changes in epidermal peroxisome proliferator-activated receptor / expression dictate wound repair kinetics Journal of Biological Chemistry 2005 280 18 18163 18170 (Pubitemid 41389061)
135. Chong H. C., Tan M. J., Philippe V., Tan S. H., Tan C. K., Ku C. W., Goh Y. Y., Wahli W., Michalik L., Tan N. S., Regulation of epithelial-mesenchymal IL-1 signaling by PPAR / is essential for skin homeostasis and wound healing Journal of Cell Biology 2009 184 6 817 831